latest news releases from the newsroom
Crucell and DSM Announce PER.C6 Licensing Agreement with Micromet for Monoclonal Antibody Production
LEIDEN, The Netherlands, Nov. 19, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they have signed a PER.C6(R) research license agreement with Micromet AG. This license agreement allows Micromet to use the PER.C6(R) cell line for evaluating the expression of certain recombinant monoclonal antibody products and subsequent preclinical manufacturing.
AB Volvo Announces Share Repurchase
GOTEBORG, Sweden, Nov. 19, 2004 (PRIMEZONE) -- Further to the decision taken by AB Volvo's Board of Directors on June 17, 2004, regarding repurchase of own shares, AB Volvo has, on Thursday, November 18, acquired 240,000 series B shares. The shares were traded between SEK 281.00 and 282.00 with an average price of SEK 281.45.
Veridium Continues To Realize Acquisition Synergies
VANCOUVER, British Columbia, Nov. 18, 2004 (PRIMEZONE) -- ManageIR.com, an online community of growth investors, today announced the growth plans of Veridium Corporation (OTCBB:VRDM), which were discussed by Veridium's chairman and chief executive officer during an interview on The Big Business Show on www.worldtalkradio.com October 18.